Not a good buy right now for an impatient entry: price is pressing into near-term resistance (around R1/R2) while short-term downside probabilities skew negative.
Trend is bullish, but momentum is getting stretched (RSI ~67) and risk/reward is less attractive at pre-market ~$55.25.
Options sentiment is bullish (very low put/call), but options activity is not elevated versus normal, suggesting no strong “must-buy-now” positioning.
Net: HOLD / avoid chasing here; a better buy would be on a pullback closer to the ~$53.3 pivot (or below) where upside-to-resistance improves.
Technical Analysis
Pre-market price: ~$55.25, slightly above R1 (55.135) and below R2 (56.282) → near-term upside is capped unless it breaks and holds above ~56.3.
Pattern-based forecast provided: 60% chance of -2.18% next day, -3.04% next week, -2.66% next month → near-term bias is down despite the bullish trend structure.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/sentiment: Open interest P/C = 0.33 and volume P/C = 0.21 → call-heavy, generally bullish sentiment.
Activity: today’s volume 226 vs 30-day average at ~64.94% → below-average volume, not a high-conviction “crowd rush.”
Volatility: 30D IV 36.35 vs historical vol 32.58 → options are pricing slightly higher future moves than recent realized.
IV percentile 38 / IV rank 7.13 → not expensive relative to its own history; volatility is not flashing a major fear spike.
Technical Summary
Sell
4
Buy
10
Positive Catalysts
can be seen as continuity and execution focus.
Neutral/Negative Catalysts
with RSI elevated → higher odds of a pullback than an immediate smooth breakout.
Financial Performance
Latest quarter: 2025/Q4.
Revenue: $808.682M, -4.10% YoY (snapshot) → top-line contraction in the latest quarter per provided financials.
Net income: $49.863M, -40.75% YoY → significant profitability decline.
EPS: $0.46, -42.50% YoY → earnings down materially YoY.
Gross margin: 97.2%, -0.17% YoY → margin slightly softer; the bigger issue is earnings decline.
Takeaway: growth trends in the latest quarter skew negative (especially earnings), which makes chasing near resistance less attractive.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent rating/target trend: mostly upward target revisions in late Jan (UBS to $59 Neutral; KBW to $62 Outperform) plus a new Buy initiation from BofA at $65; however Morgan Stanley remains Underweight with a $59 PT and flagged weaker advisory expectations.
Wall Street pros: (1) diversified model with asset management + advisory, (2) potential M&A cyclical tailwinds, (3) turnaround/inflection narrative.
Wall Street cons: (1) earnings/profitability volatility, (2) advisory revenue sensitivity (MS cut estimates), (3) valuation/expectations risk after an uptrend.
Overall Street stance: constructive but mixed—more positive PT momentum, yet not a consensus “pound-the-table” setup.
Wall Street analysts forecast LAZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LAZ is 54.5 USD with a low forecast of 46 USD and a high forecast of 59 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Analyst Rating
Wall Street analysts forecast LAZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LAZ is 54.5 USD with a low forecast of 46 USD and a high forecast of 59 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
2 Sell
Hold
Current: 54.460
Low
46
Averages
54.5
High
59
Current: 54.460
Low
46
Averages
54.5
High
59
UBS
Michael Brown
Neutral
maintain
$54 -> $59
AI Analysis
2026-01-30
Reason
UBS
Michael Brown
Price Target
$54 -> $59
AI Analysis
2026-01-30
maintain
Neutral
Reason
UBS analyst Michael Brown raised the firm's price target on Lazard to $59 from $54 and keeps a Neutral rating on the shares.
Keefe Bruyette
Alex Bond
Outperform
maintain
$59 -> $62
2026-01-30
Reason
Keefe Bruyette
Alex Bond
Price Target
$59 -> $62
2026-01-30
maintain
Outperform
Reason
Keefe Bruyette analyst Alex Bond raised the firm's price target on Lazard to $62 from $59 and keeps an Outperform rating on the shares.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LAZ
